| __timestamp | BioCryst Pharmaceuticals, Inc. | Novo Nordisk A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 7461000 | 26760000000 |
| Thursday, January 1, 2015 | 13047000 | 32169000000 |
| Friday, January 1, 2016 | 11253000 | 32339000000 |
| Sunday, January 1, 2017 | 13933000 | 32124000000 |
| Monday, January 1, 2018 | 29514000 | 33313000000 |
| Tuesday, January 1, 2019 | 37121000 | 35830000000 |
| Wednesday, January 1, 2020 | 67929000 | 36886000000 |
| Friday, January 1, 2021 | 118818000 | 41058000000 |
| Saturday, January 1, 2022 | 159371000 | 50684000000 |
| Sunday, January 1, 2023 | 213894000 | 61598000000 |
| Monday, January 1, 2024 | 67377000000 |
Cracking the code
In the world of pharmaceuticals, operational efficiency is key. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Novo Nordisk A/S and BioCryst Pharmaceuticals, Inc. from 2014 to 2023. Novo Nordisk, a global leader in diabetes care, consistently outpaces BioCryst in SG&A spending, reflecting its expansive market reach and operational scale. In 2014, Novo Nordisk's SG&A expenses were nearly 3,600 times higher than BioCryst's. By 2023, this gap narrowed slightly, with Novo Nordisk's expenses being about 290 times higher. BioCryst, a smaller player focusing on rare diseases, has seen its SG&A expenses grow by approximately 2,800% over the decade, indicating strategic investments in growth. This trend highlights the contrasting strategies of a global giant versus a niche innovator in the pharmaceutical industry.
Cost Management Insights: SG&A Expenses for Novo Nordisk A/S and Neurocrine Biosciences, Inc.
Cost Management Insights: SG&A Expenses for Novo Nordisk A/S and Intra-Cellular Therapies, Inc.
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and Biogen Inc.
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and Madrigal Pharmaceuticals, Inc.
Novo Nordisk A/S and Walgreens Boots Alliance, Inc.: SG&A Spending Patterns Compared
Novo Nordisk A/S vs Grifols, S.A.: SG&A Expense Trends
Comparing SG&A Expenses: Bio-Techne Corporation vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and BioCryst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and BioCryst Pharmaceuticals, Inc.
PTC Therapeutics, Inc. or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Catalyst Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: MannKind Corporation vs BioCryst Pharmaceuticals, Inc.